{"name":"Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)","slug":"morphic-therapeutic-inc-a-wholly-owned-subsidiary-of-eli-lilly-and-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNNGVpUFhJZW9tODl4ZFRiMGM5NDljUW9LRHppUVM2bXBVbFhUMEVWX1RCanQ3dWt5WV9URl9zLVVaVVpJa0lIbUNNYTNnRGduRE5iTGoyeUlNSm9zQ2ROSkZDZmQ4QUF3R0cyWTIzcTFBX1BTRXRYLU5kSVBFdnJMNi1CX1dLWm5tdEdoLU5UUVplOFdhUEVuZ1pvX3JnZFRWYVgwY0RmV1JSdWhMZVhSdTBJX3VTZ25EYzhBUkl3NkpyRTdxNXZybXhoZ1NreTZ6RWgxb3FtSVVKSXJLVTRvVEZkME1zS2VKdUFGWVdlZENfUnd3d3owdjBnMkdfdC1y?oc=5","date":"2026-01-27","type":"pipeline","source":"The Globe and Mail","summary":"Hard-to-Treat Cancers: How 2026’s Top Clinical Platforms Are Beating Industry Benchmarks - The Globe and Mail","headline":"Hard-to-Treat Cancers: How 2026’s Top Clinical Platforms Are Beating Industry Benchmarks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxOSzdnVnlZUUVqeWh3cVJvYURqaTliVVhtNnJ1WWIzZDhDdjN0TDA2Rzc5Y1NOcEpDN2dfa19lWDNtNEVvMjVDVzluZU1mWFhiOE9GNEJncTI4OGpENjJTSkd0RmNuSktWNnh3cmlRV3lLUHpHRzBXY1hfZGJ1ZmdEVTU5NEppQVRtWXdrRXRDUlhaRTh2S2dnaEVUcTh1aVFVSjVVbUNZSUtXdlh3a2VOamh2LUJIb2lXOGxtcDhrXzhiSDN6R3ctZmhqSXlvcGdfcHcyWXpIcjdyRXc?oc=5","date":"2025-02-24","type":"pipeline","source":"prnewswire.com","summary":"Crescent Biopharma Strengthens Leadership Team with Appointment of Three Key Executives - prnewswire.com","headline":"Crescent Biopharma Strengthens Leadership Team with Appointment of Three Key Executives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiR0FVX3lxTE5TTVBrX1lpTXp1a0hpLW5hWXpmXzEzZjAtZlUxNkJia2NETFlpMGlVUmhDWjRnWVdITmhPTTJoTTZRUW9VQkFz?oc=5","date":"2025-01-22","type":"deal","source":"Hunterbrook","summary":"Schrödinger: The Nvidia Biotech Partner Jensen Huang Told To “Think Bigger” - Hunterbrook","headline":"Schrödinger: The Nvidia Biotech Partner Jensen Huang Told To “Think Bigger”","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQRDR3cHU4SDZ5MDZ4OWpNZGpPOEJKWnlXRDhiOEsxMExfUUR0R3dNVjBCbXdka1prNnlaaGk5Z1Nrb1REb0lHbVZkTlNtZk5yQUY2TzM1U3hwcmhSMkJBdmRGMXpLOUVJQ2VHazJtbk1kcUFPbmpETVpfNmlUbUNqdDJvRFIzaGpMdGQyaTlzdXRJY1VlbU5GYW9HRzRRV1p2akJOZFV2dENpV1M1XzJLTS16NV8xTjF6UGc?oc=5","date":"2025-01-20","type":"deal","source":"Citeline News & Insights","summary":"In Vivo’s Deal Of The Year: Cast Your Vote! - Citeline News & Insights","headline":"In Vivo’s Deal Of The Year: Cast Your Vote! - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBBeWgyR1RtQnUzT3FsbEFCSlA5U1ZuMFNNSzdmSlRZXzlIaUptWkZXNy1XSmh4a1F6WkdWM2dxS2I0bER5YjZLcU44dDNoeTd5Vm14ZF80V1RUdTJJLUZwTlc5NngxSFE4UUVsV01Lb1JrWUFz?oc=5","date":"2025-01-13","type":"deal","source":"Fierce Pharma","summary":"The top 10 biopharma M&A deals of 2024 - Fierce Pharma","headline":"The top 10 biopharma M&A deals of 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFB0UGs3SEFpZVVVZUstS1pKNm5RSl9JRnItVHFwNHhVOTZoNnhjQWpTN2VzWURNbWh5Zm5ZV0FRejNUZUMwaHFvdVJzaVkxV3RmTk1HNi1uQ3lRWGZBVjQzY0d3?oc=5","date":"2024-09-11","type":"pipeline","source":"Market.us Scoop","summary":"Top 10 Smart Pill Providers | Top Medical Technology - Market.us Scoop","headline":"Top 10 Smart Pill Providers | Top Medical Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE5PMWdKcENFb2t1V2RVS3BWRERfMGNINFJaNHFhYXNsT2ZTVXplSGV3MGZLaDhrNjdfMElNb3FHVEpSdXg3NXNVckxLbXJ2a1ZNTmNhaVR5S0Q1bjVkdTZtVVhWZw?oc=5","date":"2024-08-19","type":"deal","source":"Pharmaceutical Executive","summary":"Lilly Acquires Morphic - Pharmaceutical Executive","headline":"Lilly Acquires Morphic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQV3Bxb0JZdnJsbEFGX29jT1JKeG9FWTM5ZXdzOVFQQlhCMnpnNC0wRjQxeHJpSEZoeVR1VXpMcVc0cjN3N0VERVJyRDhaN0ZMX2x1WVRtOUpQM2tqMEZEVm0yOWduQkowbllJLUdwaFVyOThFSzcweU92UzNtekhMSWpPN013UUtPTjNGNXFiNVVWZ2xjV2xieVNUZklfcUU4blpYUTFFaGZyMTIzQUVTclA1ejc5VFl5dDBrRE04NA?oc=5","date":"2024-07-08","type":"deal","source":"Eli Lilly","summary":"Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease - Eli Lilly","headline":"Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOdEczMWw3N2ZRNzVDNHExNHBQd25GS1p5emtXaFNBTjBZX0pTUEZHMmg1d214OHA3ZXBKcG5JaXE3amNnYnFfX2pOeDk5TURncW9yTTBxWE1BWGcxMHFLYWFNZUZScDNLdGxlUTRyNE5RSkNKQzJvdGZFdHBENl94aHlCSmxNNDRoRG1SY0ZDeHU?oc=5","date":"2024-05-02","type":"pipeline","source":"Yahoo Finance","summary":"Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developing Therapies - Arena Pharmaceuticals, Pfizer, Abivax, Janssen, Celgene, Eli Lilly","headline":"Inflammatory Bowel Disease Market To Exhibit Significant Growth by 2032, Predicts DelveInsight | Key Companies Developin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNaGFRMHFFVlBvMWJDa2x0b1Fzb0FiVTBMVDFWem52YWRIS3V1a0RnUnQ4V0hpU2QtMTdMLTAyOC02LWV5dWd2NzZzNDlMTkhXRmxvazhVMUY4SERoV2E0YmxmNFBhR1J1N3BxNDN2anpSYXVfZlZXQXZYcW9OY2loMTVITDlZeW1GMEpibTg2TmNDaGVYX2ZLNjlqZk1leWR1ekE?oc=5","date":"2024-01-31","type":"deal","source":"Contract Pharma","summary":"Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma","headline":"Pharmaceutical Industry Mergers & Acquisitions Roundup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQMGdmVzlaczhPU20yWjdKalpsWXJDTFRCQjJNNGZGYTVzNmtLdWZxX2xyLUJKTjZRdVFfT3NCSWdfQ3RtRFYwdWxjNFdNZHRtcEl1c3dyWlJRSk1qUHRBQktRTGlOTFZmMlFOakxLQWZwS0prWXZwV3ZiQ2FIMjN6bXFEWWV1QlZZY21rVHg4clY0ckoxWVhqbXFFWDd6Z3lXLXlQUVFpZ183TTNNeEpGbVZNLWZtcHYzU1ZZUg?oc=5","date":"2023-08-18","type":"earnings","source":"Genetic Engineering and Biotechnology News","summary":"Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery - Genetic Engineering and Biotechnology News","headline":"Schrödinger’s Equation: Physics + Machine Learning = Drug Discovery","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQSG5nLTdselhIUU9zaVotZjVRSG5aemJMbDFBNmk4NDNrTnR3dGd3ZWY1Z0EtZldMYVJXa2pHLW5Zam9nb0h2Z3ZzcXVBTnA5cTY2YU0zRVU3bURNRkRaV21ycWJvSXZzQUxyTWo3TnNqVG0tNFJTd0ktclI2NV80bllTbWpvNzFvTl9n?oc=5","date":"2023-03-02","type":"trial","source":"The Lancet","summary":"Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies - The Lancet","headline":"Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-c","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}